NEWS! Our SAECG technology shows positive results in NIH-Funded Multi-Center Study! View Here!

The world’s finest signal averaging, cardiovascular & hemodynamics products.

Arrhythmia Research Technology, Inc. (ART) was founded in 1981 specifically to capitalize on the marketing of certain patents or licenses concerning the application of signal-averaged electrocardiography (SAECG) for the detection of cardiac late potentials. Today, ART continues to broaden its portfolio of solutions and products through the acquisition and deployment of world class technologies, people and processes.

Across virtually every industry, design engineers and scientists are confronted with the increasingly difficult challenge of creating a superior product that can be priced to succeed in today’s highly competitive global marketplace.  ART is uniquely positioned to understand the design and manufacturing challenges you face.  Through its subsidiary Micron Products, Inc. we have the experience and capabilities to develop and manufacture exceptional products that result in total product quality, greater efficiency and lower project costs.

Comments on this entry are closed.